Exklusiver Live-Stream direkt von der World of Trading - 2 Tage mit einzigartigen Themen und Experten. Kostenlos teilnehmen + Videos erhalten. -w-
06.03.2006 17:44:00

Analogic Corporation Launches the LIFEGARD II Family of Non-Invasive Patient Monitors at the ACC in Atlanta, March 11-14

Analogic Corporation (NASDAQ: ALOG) today announced theofficial product launch of the LIFEGARD(R) II family of non-invasivepatient monitors at ACC.06 (American College of Cardiology), March11-14, 2006, in Atlanta, Georgia (Booth #3432).

The LIFEGARD II, the latest in a series of non-invasive patientmonitors from Analogic, is the platform upon which the Company willexpand its patient monitoring offerings. LIFEGARD II with ICG(Impedance CardioGraphy) uses Thoracic Electrical Bioimpedance (TEB)to measure continuous cardiac output, and is the only patient monitorthat has ICG totally integrated with all other standard, non-invasivevital signs.

Non-invasive hemodynamic measurement is a valuable, establishedtool in managing cardiac patients, and the LIFEGARD II with ICG is themost comprehensive non-invasive cardiac output monitor availabletoday.

Dan Webster, General Manager of Analogic's Life Care SystemsDivision, noted, "The LIFEGARD II family represents a significantexpansion of our growing LIFEGARD family of patient monitors. Thenon-invasive, portable LIFEGARD II with ICG adds a new level ofversatility to patient monitoring by allowing clinicians to morecomprehensively monitor patient hemodynamics anywhere in the hospitalor in non-acute environments such as freestanding clinics andphysicians' offices. Clinicians can evaluate a patient in considerablyless time and with no risk of infection, compared to conventionalinvasive monitoring modalities."

Analogic's LIFEGARD family of non-invasive patient monitors alsoincludes LIFEGARD, a general-purpose monitor that measures ECG, heartrate, respiration, pulse oximetry, non-invasive blood pressure, andtemperature; LIFEGARD ICG, a non-invasive hemodynamic status monitor;and the FETALGARD Lite(R) and FETALGARD Lite with NIBP, antepartumfetal monitors capable of monitoring twins. LIFEGARD II multiparametermonitors can also measure end-tidal CO2, in addition to ICG and thefive standard vital sign parameters. Additional models with expandedcapabilities which have already received U.S. Food & DrugAdministration (FDA) clearance will be made available over the next 12months. For more information, visit Booth #3432 at ACC in Atlanta, goto www.analogic.com/lifegard, or call 800-599-7769.

Analogic Corporation is a leading designer and manufacturer ofadvanced health and security systems and subsystems sold primarily toOriginal Equipment Manufacturers (OEMs). The Company is recognizedworldwide for advancing the state of the art in Computed Tomography(CT), Digital Radiography (DR), Ultrasound, Magnetic Resonance Imaging(MRI), Patient Monitoring, and Embedded Multiprocessing.

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Nachrichten zu Analogic Corp.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Analogic Corp.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Indizes in diesem Artikel

NASDAQ Comp. 19 003,65 0,16%